Patents by Inventor Kenneth E. Kinnamon

Kenneth E. Kinnamon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic and aromatic thiosemicarbazones useful in the treatment of filariasis
    Patent number: 5281597
    Abstract: This invention is directed to heterocyclic and aromatic thiosemicarbazones seful in the treatment of filariasis and in an animal, including humans.
    Type: Grant
    Filed: November 8, 1991
    Date of Patent: January 25, 1994
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: John W. McCall, Daniel L. Klayman, Ai Jeng Lin, Kenneth E. Kinnamon, Max Grogl
  • Anti-leishmanial lepidine derivatives
    Patent number: 4209519
    Abstract: The subject 8-amino-6-methoxy lepidine derivatives have the formula: ##STR1## wherein, R represents an --alkylene (tertiary) amine, --alkylene-NH.sub.2, (N-alkylsubstituted piperadyl amino)-alkylene-, --alkylene-(tertiary) amine or --alkylene-N-heterocyclic; R.sub.1, represents an alkoxy, alkyl, halogenated alkyl, alkenyl, aryloxy, halogen or hydrogen radical; R.sub.2 represents an alkyl, halogenated alkyl or aryloxy; n represents integers 3, 4, 5, 6 or 7; and pharmaceutically acceptable salts thereof wherein the salt forming acid or acid-hydrate is organic or inorganic. These derivatives afford improvement in means for the chemotherapy of leishmaniasis. Presence of a basic sidechain attachment at position 8- provides means for enhancement of the effectiveness of such compounds, which may be administered parenterally or orally to infected animals.
    Type: Grant
    Filed: March 13, 1978
    Date of Patent: June 24, 1980
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Kenneth E. Kinnamon
  • Use of phosphonium salts in treatment of African trypanosomiasis
    Patent number: 4187300
    Abstract: Subject triaryl benzyl phosphonium salts afford new means for the treatment f African trypanosomiasis. Such compounds may be administered safely to infected animals either parenterally or orally.
    Type: Grant
    Filed: December 20, 1978
    Date of Patent: February 5, 1980
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventor: Kenneth E. Kinnamon